Related Experiment Video
Updated: Aug 14, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Multi-Modal Ultrasound-Based Prognostic Model for Diffuse Large B-Cell Lymphoma with Predominantly Superficial Lymph
Jingzhe Wang1,2,3,4,5, Jie Mu1,2,3,4,5, Yichen Yang2,3,4,5,6
1Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Diagnostics (Basel, Switzerland)
|August 13, 2026
Summary
A new ultrasound model combining radiomics, deep learning, and clinical data accurately predicts progression-free survival (PFS) in diffuse large B-cell lymphoma (DLBCL) patients with superficial lymph node involvement.
Area of Science:
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Accurate prognostic models are crucial for guiding treatment decisions in DLBCL.
- Superficial lymph node involvement is a common presentation in DLBCL.
Purpose of the Study:
- To develop and validate a multi-modal ultrasound-based predictive model for progression-free survival (PFS) in DLBCL patients.
- To integrate radiomics, deep learning, and clinical features for enhanced prognostic accuracy.
- To assess the model's performance using C-index, AUC, and risk stratification.
Main Methods:
- Retrospective analysis of 281 DLBCL patients with superficial lymph node involvement.
- Extraction of ultrasound radiomic features and deep learning features using DenseNet121.
- Feature selection via Pearson's correlation and LASSO-Cox regression.
- Development and comparison of five prognostic models.
Main Results:
- The combined multi-modal model achieved a high C-index of 0.811 in the test set.
- The model demonstrated strong 1-, 2-, and 3-year PFS prediction with AUCs around 0.81-0.83.
- High-risk stratification group showed significantly poorer PFS (p < 0.01).
Conclusions:
- A multi-modal ultrasound model integrating radiomics, deep learning, and clinical data shows significant promise for PFS prediction in DLBCL.
- The developed nomogram offers a practical tool for individualized prognostic assessment and risk stratification.
- This approach facilitates intuitive and effective patient management in DLBCL.

